Navigating the complexities of providing advanced analytical assays for new vaccines and modern cell and gene therapy products can be challenging due to evolving technologies and regulatory requirements.
At IDT Biologika, we offer comprehensive characterisation and release testing of biological materials, utilising a broad range of conventional and innovative assays to ensure safety and compliance.
Join our webinar to explore how modern technologies are transforming vaccine safety testing and process transparency.
What you will learn:
- Innovative methods for adventitious virus detection
- How to troubleshoot common challenges in biological testing
- A case study on validating a new an NGS-driven AVT assay
You will also have the chance to connect directly with our experts during the Q&A session.
Don’t miss this opportunity – click here to register for free today.